AVM is a development-stage biotech company advancing the research, development and commercialization of game-changing stem cell technologies for high unmet medical needs in regenerative medicine, cancer treatment recovery, safer iPS cell culturing and treatment, and fully human biologics, including patient-specific biologics for personalized medicine (“Boutique Biologics™”) in orphan diseases.

Biotechnology

AVM Biotech

Theresa A. Deisher, Ph.D.

Todd Bertsch

Siuliana Limasi

Manisha Pathak

Terry Kopp

Mia Lor

Jena Dalpez

The Research & Development team at AVM Biotech is dedicated to pioneering innovative stem cell technologies and advancing contributions to regenerative medicine and personalized treatment. Comprising scientific advisors and researchers, the team focuses on designing and conducting experiments, analyzing results, and collaborating with clinical experts to ensure the effective development and commercialization of bespoke biologics for patients with unmet medical needs. Their work is essential in transforming laboratory breakthroughs into viable therapeutic solutions.

Research & Development

Leadership Team

Research & Development

About

Team members

Other teams at AVM Biotech

Leadership Team